Research Article
Simultaneous Spectrophotometric Estimation of Artesunate and Mefloquine
Table 5
Results of marketed tablet formulation.
| Sr. no. | Label claim (mg/tab) | Amount found (mg/tab) | % of Label claim | ART | MEF | ART | MEF | ART | MEF |
| | 100 | 200 | 99.63 | 198.72 | 99.63 | 99.36 | | 100 | 200 | 99.70 | 199.44 | 99.70 | 99.72 | | 100 | 200 | 100.02 | 198.88 | 100.02 | 99.44 | | 100 | 200 | 99.91 | 199.96 | 99.91 | 99.98 | | 100 | 200 | 99.86 | 198.96 | 99.86 | 99.48 | | 100 | 200 | 99.57 | 200.36 | 99.57 | 100.18 |
| | | | | Mean | 99.78 | 99.69 | | | | | SD | 0.1754 | 0.3287 | | | | | % RSD | 0.1757 | 0.3297 |
|
|
Formulation: Falcigo Plus (Zydus Cadila Pharmaceutical Ltd., Ahmadabad).
|